A recent Government Accountability Office report highlights the FDA’s infrequent removal of defective medical devices from the market, attributing this to understaffing issues. The report suggests that the FDA struggles to ensure that manufacturers implement necessary measures to safeguard patients. This situation raises concerns about the agency’s capacity to effectively regulate medical devices under the Trump administration, potentially impacting patient safety and industry compliance.
